Check how courts have cited this case. Use our free citator for the most current treatment.
No. 10306237
United States Court of Appeals for the Ninth Circuit
Hable v. Godenzi
No. 10306237 · Decided December 31, 2024
No. 10306237·Ninth Circuit · 2024·
FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Ninth Circuit
Decided
December 31, 2024
Citation
No. 10306237
Disposition
See opinion text.
Full Opinion
NOT FOR PUBLICATION FILED
UNITED STATES COURT OF APPEALS DEC 31 2024
MOLLY C. DWYER, CLERK
U.S. COURT OF APPEALS
FOR THE NINTH CIRCUIT
PATRICK HABLE, No. 24-646
D.C. No.
Plaintiff - Appellant, 2:22-cv-02012-GMN-BNW
v.
MEMORANDUM*
BENN GODENZI,
Defendant - Appellee.
Appeal from the United States District Court
for the District of Nevada
Gloria M. Navarro, District Judge, Presiding
Argued and Submitted December 2, 2024
San Francisco, California
Before: BENNETT, BRESS, and FORREST, Circuit Judges.
Dissent by Judge BRESS.
Appellant Patrick Hable appeals from the district court’s order dismissing his
federal and state securities fraud claims against Appellee Benn Godenzi. We have
jurisdiction under 28 U.S.C. § 1291, and we affirm.
“We review de novo dismissals for failure to state a claim under Federal Rule
*
This disposition is not appropriate for publication and is not precedent
except as provided by Ninth Circuit Rule 36-3.
of Civil Procedure 12(b)(6).” Rubke v. Capitol Bancorp Ltd., 551 F.3d 1156, 1161
(9th Cir. 2009). We accept all well-pleaded allegations as true. Lloyd v. CVB Fin.
Corp., 811 F.3d 1200, 1205 (9th Cir. 2016).
1. Section 10(b) and Rule 10b–5 claim. “To state a claim under Section
10(b) and Rule 10b-5(b) [of the Securities Exchange Act of 1934], plaintiffs must
allege: (1) a material misrepresentation or omission (‘falsity’), (2) made with
scienter, (3) in connection with the purchase or sale of a security, (4) reliance on the
misrepresentation or omission, (5) economic loss, and (6) loss causation.” In re
Genius Brands Int’l, Inc. Sec. Litig., 97 F.4th 1171, 1180 (9th Cir. 2024). Hable’s
claim asserted under Section 10(b) and Rule 10b–5 is subject to the heightened
pleading standard required by the Public Securities Litigation Reform Act (PSLRA)
and Rule 9(b) of the Federal Rules of Civil Procedure. Id. The PSLRA requires that
the complaint “specify each statement alleged to have been misleading, the reason
or reasons why the statement is misleading, and, if an allegation regarding the
statement or omission is made on information and belief, the complaint shall state
with particularity all facts on which that belief is formed.” 15 U.S.C. § 78u-4(b)(1).
Rule 9(b) similarly requires a party to “state with particularity the circumstances
constituting fraud or mistake.” Fed. R. Civ. P. 9(b). “These heightened standards
apply ‘to all elements of a securities fraud action.’” In re Genius Brands Int’l, 97
F.4th at 1181 (quoting Oregon Pub. Emps. Ret. Fund v. Apollo Grp., Inc., 774 F.3d
2 24-646
598, 605 (9th Cir. 2014)).
Falsity. To plead falsity, a complaint “must allege a misrepresentation or a
misleading omission with particularity and explain why it is misleading.” Retail
Wholesale & Dep’t Store Union Loc. 338 Ret. Fund v. Hewlett-Packard Co., 845
F.3d 1268, 1274 (9th Cir. 2017). “[Section] 10(b) and Rule 10b–5(b) do not create
an affirmative duty to disclose any and all material information. Disclosure is
required under these provisions only when necessary ‘to make . . . statements made,
in the light of the circumstances under which they were made, not misleading.’”
Matrixx Initiatives, Inc. v. Siracusano, 563 U.S. 27, 44 (2011) (alteration in original)
(quoting 17 C.F.R. § 240.10b–5(b)). “[A] statement is misleading if it would give a
reasonable investor the ‘impression of a state of affairs that differs in a material way
from the one that actually exists.’” Retail Wholesale, 845 F.3d at 1275 (alteration in
original) (quoting Berson v. Applied Signal Tech., Inc., 527 F.3d 982, 985 (9th Cir.
2008)).
Here, Hable contends that Godenzi’s statements about litigation he filed in
Singapore against Ecomi Technology PTE Limited—that “[t]he dispute was settled
and we parted ways amicably” and that “the [Ecomi] team didn’t pay our contract
for a year which led to a lawsuit and of course a settlement”—gave the misleading
impression that Godenzi had no ongoing legal disputes with Ecomi. However, read
in context, Godenzi’s statements referred specifically to the Singapore litigation.
3 24-646
Godenzi therefore did not have a duty to disclose the New Zealand lawsuit that he
brought against Ecomi’s parent company when he made the challenged statements
about the Singapore litigation. Moreover, Hable failed to allege why a reasonable
investor would interpret Godenzi’s challenged statements to mean that all litigation
between him and Ecomi and its parent company was resolved. See 15 U.S.C. § 78u-
4(b)(1) (requiring a complaint to specify “the reason or reasons why the statement is
misleading”). Accordingly, Hable failed to adequately allege falsity.1
Scienter. To plead scienter, “a complaint must ‘allege that the defendants
made false or misleading statements either intentionally or with deliberate
recklessness.’” Nguyen v. Endologix, Inc., 962 F.3d 405, 414 (9th Cir. 2020)
(quoting Zucco Partners, LLC v. Digimarc Corp., 552 F.3d 981, 991 (9th Cir.
2009)). Deliberate recklessness is “‘an extreme departure from the standards of
ordinary care,’ which ‘presents a danger of misleading buyers or sellers that is either
known to the defendant or is so obvious that the actor must have been aware of it.’”
Id. (emphasis in original) (quoting Schueneman v. Arena Pharm., Inc., 840 F.3d 698,
705 (9th Cir. 2016)). A complaint adequately pleads scienter when, viewing all the
allegations holistically, “a reasonable person would deem the inference of scienter
1
Hable’s additional arguments that the two lawsuits were closely related and
that Godenzi’s statements were capable of objective verification do not cure the First
Amended Complaint’s deficiencies under the heightened pleading standards of the
PSLRA and Rule 9(b).
4 24-646
cogent and at least as compelling as any opposing inference one could draw from
the facts alleged.” Matrixx Initiatives, 563 U.S. at 48 (quoting Tellabs, Inc. v. Makor
Issues & Rts., Ltd., 551 U.S. 308, 324 (2007)).
Here, Hable’s allegations do not support a “strong inference” that Godenzi
was “intentionally or with deliberate recklessness seeking to mislead the market
about” the status of his legal disputes with Ecomi. Nguyen, 962 F.3d at 419. Rather,
the more plausible inference is that Godenzi was merely explaining that the
Singapore litigation was resolved.
Because Hable failed to adequately allege falsity and scienter, we affirm the
district court’s dismissal of his federal securities fraud claim. See No. 84 Emp.-
Teamster Joint Council Pension Trust Fund v. America West Holding Corp., 320
F.3d 920, 931–32 (9th Cir. 2003) (“If a plaintiff fails to plead either the alleged
misleading statements or scienter with particularity, his or her complaint must be
dismissed.”).
2. State law claims. Under the Nevada Securities Act, a plaintiff must
allege that the defendant “[m]a[d]e an untrue statement of a material fact or omit[ted]
to state a material fact necessary in order to make the statements made not
misleading in the light of the circumstances under which they [we]re made.” Nev.
Rev. Stat. § 90.570(2). For the reasons discussed above, Hable failed to sufficiently
allege that any of Godenzi’s statements were untrue or that disclosure of the New
5 24-646
Zealand litigation was necessary to make his statements not misleading.
Accordingly, Hable failed to state a claim under the Nevada Securities Act.
A common law fraud claim similarly requires a plaintiff to allege that the
defendant (1) made a false representation that the defendant knows or believes is
false, Barmettler v. Reno Air, Inc., 956 P.2d 1382, 1386 (Nev. 1998); or (2)
concealed or suppressed a material fact that the defendant had a duty to disclose,
Leigh-Pink v. Rio Properties, LLC, 512 P.3d 322, 325 (Nev. 2022). Because Hable
failed to sufficiently allege that Godenzi made a false representation or concealed a
material fact that he was under a duty to disclose, he also failed to state a claim for
common law fraud. Accordingly, we affirm the district court’s dismissal of Hable’s
claims under Nevada law.
AFFIRMED.
6 24-646
FILED
Hable v. Godenzi, 24-646 DEC 31 2024
MOLLY C. DWYER, CLERK
BRESS, Circuit Judge, dissenting: U.S. COURT OF APPEALS
The majority concludes that plaintiff Hable failed to plead a material
misrepresentation or misleading omission and scienter. In doing so, the majority
overlooks the most salient facts in this case and erroneously affirms the district
court’s Rule 12(b)(6) dismissal of the plaintiff’s complaint.
Defendant Godenzi was “the largest investor” in the cryptocurrency security
that he personally sold to Hable. In fact, Godenzi was not only the largest investor,
but he was also hired by Ecomi “to advise the company on how to structure” the
security. In a one-on-one conversation between Hable and Godenzi discussing
Hable’s potential purchase of the cryptocurrency, Godenzi told Hable that Ecomi
“didn’t pay our contract for a year which led to a lawsuit and of course a settlement.”
Although Godenzi mentioned that this lawsuit against Ecomi had settled (the
Singapore lawsuit), he did not mention that he still had an ongoing lawsuit against
Ecomi (the New Zealand lawsuit). In the New Zealand litigation, Godenzi alleged
that Ecomi “failed to pay him” for his investment. Moreover, the New Zealand
lawsuit was not publicly available information. Hable proceeded to purchase
approximately $12 million of the cryptocurrency from Godenzi. Several months
before the one-on-one discussion between Hable and Godenzi that led directly to the
sale of cryptocurrency, Godenzi had publicly discussed the Singapore lawsuit,
stating that “[t]he dispute was settled and we parted aways amicably.” Here too, he
did not mention the New Zealand lawsuit.
In terms of whether Godenzi made a material misrepresentation or misleading
omission, the question is whether Godenzi’s statements that one lawsuit against
Ecomi settled, without his mentioning that he had another lawsuit pending, “would
give a reasonable investor the ‘impression of a state of affairs that differs in a
material way from the one that actually exists.’” Retail Wholesale & Dep’t Store
Union Loc. 338 Ret. Fund v. Hewlett-Packard Co., 845 F.3d 1268, 1275 (9th Cir.
2017) (quoting Berson v. Applied Signal Tech., Inc., 527 F.3d 982, 985 (9th Cir.
2008)). The majority is correct that “read in context, Godenzi’s statements referred
specifically to the Singapore litigation.” But the majority is incorrect that “Godenzi
therefore did not have a duty to disclose the New Zealand lawsuit.” Rather, “‘once
defendants choose to tout’ positive information to the market, ‘they are bound to do
so in a manner that wouldn’t mislead investors,’ including disclosing adverse
information that cuts against the positive information.” Schueneman v. Arena
Pharms., Inc., 840 F.3d 698, 706 (9th Cir. 2016) (quoting Berson v. Applied Signal
Tech., Inc., 527 F.3d 982, 987 (9th Cir. 2008)).
If Godenzi had not affirmatively told Hable that Ecomi “didn’t pay our
contract for a year which led to a lawsuit and of course a settlement,” then perhaps
he would have no obligation to bring up either the Singapore litigation or the New
2 24-646
Zealand litigation. But once Godenzi “tout[ed] positive information” that the
Singapore litigation settled, he became “bound to do so in a manner that wouldn’t
mislead investors.” Schueneman, 840 F.3d at 706 (quoting Berson, 527 F.3d at 987).
This required “disclosing adverse information that cut[] against the positive
information” that the Singapore lawsuit settled, specifically that the settlement
agreement carved out Hable’s New Zealand lawsuit, which he continued to litigate.
Id.
There is no question that the Singapore lawsuit was material, especially at the
Rule 12(b)(6) stage. “The materiality of . . . an omission depends upon whether
there is ‘a substantial likelihood that [it] would have been viewed by the reasonable
investor as having significantly altered the total mix of information made available’
for the purpose of decisionmaking by stockholders concerning their investments.”
Retail Wholesale, 845 F.3d at 1274 (quoting Basic Inc. v. Levinson, 485 U.S. 224,
231–32 (1988) (internal quotations omitted)). The complaint alleges that Godenzi,
the “largest investor” in the security—who also “incubated [E]comi from the
business model to the token ecosystem”—was suing Ecomi for not complying with
the terms of his investment. A reasonable investor would view this information “as
having significantly altered the total mix of information made available” about
whether to invest in the cryptocurrency. Id. (quoting Basic Inc., 485 U.S. at 232).
For similar reasons, Hable has sufficiently pleaded scienter, which requires
3 24-646
that his complaint “allege that the defendants made false or misleading statements
either intentionally or with deliberate recklessness.” Nguyen v. Endologix, Inc., 962
F.3d 405, 414 (9th Cir. 2020) (quoting Zucco Partners, LLC v. Digimarc Corp., 552
F.3d 981, 991 (9th Cir. 2009)). A “strong inference” of scienter under the PSLRA
requires that “a reasonable person would deem the inference of scienter cogent and
at least as compelling as any opposing inference one could draw from the facts
alleged.” Id. (quoting Tellabs, Inc. v. Makor Issues & Rts., Ltd., 551 U.S. 308, 324
(2007)). The complaint alleged that Godenzi did not disclose the New Zealand
lawsuit “because he intended to sell [his cryptocurrency] that he would otherwise
have been unable to sell at his desired price or, alternatively or additionally, because
he knew that Hable would not buy the tokens if he knew the truth.”
In the New Zealand lawsuit, we have the largest investor in and the architect
of a cryptocurrency security suing the company that issued the security for not
paying him for his investment. The largest investor tells a potential buyer in a one-
on-one discussion that a different lawsuit he brought against the company has settled
without disclosing that the New Zealand lawsuit, whose existence is not public
information, is ongoing. The largest investor proceeds to offload $12 million of the
security to the buyer. A few months later, when the other lawsuit becomes public
information, the security declines 36% in value. Especially given the one-on-one
interaction between the parties, the seller’s failure to disclose to the buyer his
4 24-646
nonpublic lawsuit against the company raises a strong inference that the seller either
intended to conceal or was deliberately reckless in not disclosing the lawsuit. In this
case, “a reasonable person would deem the inference of scienter cogent and at least
as compelling as any opposing inference one could draw from the facts alleged.” Id.
(quoting Tellabs, 551 U.S. at 324).
For these reasons, I would reverse the Rule 12(b)(6) dismissal of Hable’s
securities fraud complaint. Given my reasoning on the federal claims, I would
likewise reverse on the state law claims. I respectfully dissent.
5 24-646
Plain English Summary
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS DEC 31 2024 MOLLY C.
Key Points
01NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS DEC 31 2024 MOLLY C.
02Navarro, District Judge, Presiding Argued and Submitted December 2, 2024 San Francisco, California Before: BENNETT, BRESS, and FORREST, Circuit Judges.
03Appellant Patrick Hable appeals from the district court’s order dismissing his federal and state securities fraud claims against Appellee Benn Godenzi.
04“We review de novo dismissals for failure to state a claim under Federal Rule * This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3.
Frequently Asked Questions
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS DEC 31 2024 MOLLY C.
FlawCheck shows no negative treatment for Hable v. Godenzi in the current circuit citation data.
This case was decided on December 31, 2024.
Use the citation No. 10306237 and verify it against the official reporter before filing.